GB2092130B - 4-oximino-1,2,3,4-tetrahydroquinoline derivatives - Google Patents

4-oximino-1,2,3,4-tetrahydroquinoline derivatives

Info

Publication number
GB2092130B
GB2092130B GB8120931A GB8120931A GB2092130B GB 2092130 B GB2092130 B GB 2092130B GB 8120931 A GB8120931 A GB 8120931A GB 8120931 A GB8120931 A GB 8120931A GB 2092130 B GB2092130 B GB 2092130B
Authority
GB
United Kingdom
Prior art keywords
oximino
tetrahydroquinoline derivatives
tetrahydroquinoline
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB8120931A
Other languages
English (en)
Other versions
GB2092130A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hodogaya Chemical Co Ltd
Mochida Pharmaceutical Co Ltd
Original Assignee
Hodogaya Chemical Co Ltd
Mochida Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP10327280A external-priority patent/JPS5728052A/ja
Priority claimed from JP3991081A external-priority patent/JPS57154168A/ja
Priority claimed from JP3991181A external-priority patent/JPS57154169A/ja
Application filed by Hodogaya Chemical Co Ltd, Mochida Pharmaceutical Co Ltd filed Critical Hodogaya Chemical Co Ltd
Publication of GB2092130A publication Critical patent/GB2092130A/en
Application granted granted Critical
Publication of GB2092130B publication Critical patent/GB2092130B/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/22—Oxygen atoms attached in position 2 or 4
    • C07D215/233—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38—Nitrogen atoms
    • C07D215/42—Nitrogen atoms attached in position 4

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
GB8120931A 1980-07-28 1981-07-07 4-oximino-1,2,3,4-tetrahydroquinoline derivatives Expired GB2092130B (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP10327280A JPS5728052A (en) 1980-07-28 1980-07-28 Novel 4-hydroxyimino-1,2,3,4-tetrahydroquinoline derivative
JP3991081A JPS57154168A (en) 1981-03-19 1981-03-19 Novel 4-oximino-1,2,3,4-tetrahydroquinoline derivative
JP3991181A JPS57154169A (en) 1981-03-19 1981-03-19 Novel 4-oximino-1,2,3,4-tetrahydroquinoline derivative

Publications (2)

Publication Number Publication Date
GB2092130A GB2092130A (en) 1982-08-11
GB2092130B true GB2092130B (en) 1984-05-10

Family

ID=27290305

Family Applications (1)

Application Number Title Priority Date Filing Date
GB8120931A Expired GB2092130B (en) 1980-07-28 1981-07-07 4-oximino-1,2,3,4-tetrahydroquinoline derivatives

Country Status (3)

Country Link
DE (1) DE3129718A1 (he)
FR (1) FR2487346A1 (he)
GB (1) GB2092130B (he)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2552430B1 (fr) * 1983-09-22 1985-10-25 Rhone Poulenc Sante Procede de preparation de quinolinones-4
JPS6160682A (ja) * 1984-08-30 1986-03-28 Nippon Tokushu Noyaku Seizo Kk テトラヒドロキノリン−１−イルカルボニルイミダゾ−ル誘導体、その中間体、それらの製法並びに除草又は農園芸用殺菌剤
US4839368A (en) * 1986-05-02 1989-06-13 Mochida Pharmaceutical Co., Ltd. 1-acyl-2,3-dihydro-4(1H)-quinolinone-4-oxime derivatives
JP2602037B2 (ja) * 1987-10-31 1997-04-23 持田製薬株式会社 １−アシル−２，３−ジヒドロ−４（１ｈ）−キノリノン−４−オキシム誘導体、その製法およびそれらを主成分とする利尿、降圧、抗浮腫および腹水除去用医薬組成物
US8697674B2 (en) 2004-12-29 2014-04-15 Naturon, Inc. Xanthurenic acid derivative pharmaceutical compositions and methods related thereto

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3075984A (en) * 1958-05-09 1963-01-29 Sterling Drug Inc 1-[(lower-aromatic)-(lower-alkyl)]-4-[(lower-aromatic)-(lower-alkyl) imino]-1, 4-dihydroquinolines and their preparation
US3406176A (en) * 1964-08-24 1968-10-15 Sterling Drug Inc 7-halo-4-carbamylimino-1, 4-dihydroquinolines

Also Published As

Publication number Publication date
GB2092130A (en) 1982-08-11
DE3129718C2 (he) 1988-08-18
FR2487346B1 (he) 1984-12-28
DE3129718A1 (de) 1982-04-15
FR2487346A1 (fr) 1982-01-29

Similar Documents

Publication Publication Date Title
GB2118556B (en) 26,26,26,27,27,27-hexafluoro-cholesterol derivatives
GB2068382B (en) 25-hydroxy-26,26,26,27,27,27-hexafluorocholecalciferol
AU7338081A (en) 1,2,4-triazolylpropenol derivatives
GB2098203B (en) Novel 4,5-diaryl-thiazole-2-thiol derivatives
GB2073752B (en) 2,6-diaminobularines
GB2075012B (en) 4,1-benzoxazepines
GB2135303B (en) 3,5-dinitrophthalimides
GB2070588B (en) Carbostyril derivatives
JPS5732239A (en) 2,3-bis-hydroxybenzyl derivative
GB2092130B (en) 4-oximino-1,2,3,4-tetrahydroquinoline derivatives
GB8301383D0 (en) 3,3-dialkyl-and 3,3-alkylene-indoline derivatives
JPS57116050A (en) 2,4-diamino-5-benzylpyrimidine
HK51487A (en) 17,18-dehydro-apovincaminol derivatives
GB2086387B (en) 1,8-dihydroxy-9-anthrones
ZA825796B (en) 1,2-dithiol-3-ylideneammonium derivatives
GB2080794B (en) 1,6-naphthyridine derivatives
GB2080791B (en) 1,4-benzoxazines
GB2138812B (en) 8-benzylidene-5,6,7,8-tetrahydroquinoline derivatives
GB2086879B (en) 5-aryl-6h-1,3,4-thiadiazine-2-amines
AU7744681A (en) 2,3-dihydro-4-pyrone derivatives
ZA823838B (en) 1,2,3,4,4a,9b-hexahydro-4a-piperazinylmethyl-4-dibenzofuranone or-dibenzofuranol derivatives
ZA81222B (en) 1,3-diformyloxy -2-bromo-2-nitropropane
AU542710B2 (en) 16-amino-17-phenyl-18,19,20-trinor-prosta-glandin derivatives
IL68335A0 (en) 1,3,5-triacrylylhexahydro-s-triazine derivatives
GB2108956B (en) 6-alkyl-1,2-dihydro-2-oxopyridine derivatives

Legal Events

Date Code Title Description
PCNP Patent ceased through non-payment of renewal fee